Biggest News Aggregation in the World
๐Ÿ“ฐ Looking Statement News

Page 58 - Looking Statement News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Looking Statement. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Merck & Co., Inc.: Merck Receives Positive EU CHMP Opinion for KEYTRUDA (pembrolizumab) as Adjuvant Treatment for Adult and Adolescent (=12 Years of Age) Patients With Stage IIB or IIC Melanoma Following Complete Resection

Opinion granted based on positive results from the Phase 3 KEYNOTE-716 trial If approved, KEYTRUDA would be the first anti-PD-1 immunotherapy treatment option for patients 12 years and older in
United States Scot Ebbinghaus Peter Dannenbaum Damini Chokshi Melissa Moody Merck Research Laboratories

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science